Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining conventional and integrative treatments can help reduce hair loss and improve hair growth in women with androgenic alopecia.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Advanced platelet-rich fibrin improves healing and reduces pain in oral surgery.

Oral baricitinib is effective and safe for treating alopecia areata.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

YiFa compound serum may help treat hair loss by boosting hair follicle stem cell activity.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Candida antigen is an effective and promising treatment for alopecia areata.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Atopy and altered T cell functions contribute to Alopecia Areata.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Biocompatible artificial hair implants significantly improved patients' quality of life and were successful.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Baricitinib is an effective treatment for severe alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Combining laser light therapy and growth factor treatment improves hair growth in people with hair loss.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.